About Advitech
Advitech Inc., a health sciences and technology company, engages in the research, development, and commercialization of nutraceutical ingredients and products to prevent immune-mediated inflammatory disorders, such as psoriasis, eczema, and inflammatory bowel disease. The company offers Dermylex for the treatment of mild-to-moderate psoriasis; products for skin regeneration, remodeling, and skin immune support applications; and a line of bioactive growth factors for applications for the immune system and athletic performance. It also has a wound healing research program to develop applications for its XP-828L and IM technological platforms. Advitech provides its products through distributors in Canada, the United States, Mexico, Europe, France, Belgium, Taiwan, and Indonesia. The company was incorporated in 1995 and is headquartered in Québec City, Canada.
|
|
|
11-50 employees
View all Advitech employees
|
|
Biotechnology Research
|
|
(403) 770-9654
|
|
Calgary, Alberta
|
|
Unkn
|
Advitech Alternatives
Frequently Asked Questions about Advitech
The decision makers in Advitech are Christina Juneau, Erik Andersen, Eunice Ann Coertze, etc. Click to Find Advitech decision makers emails.
Advitech Staff Directory
Search Advitech Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
